A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2001
11/07/2001	EP1151121A1 Recombined porcine adenovirus based viral vaccines and vectors
11/07/2001	EP1151118A1 Recombinant expression of heterologous nucleic acids in protozoa
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151104A1 Diagnostic and protective antigen gene sequences of ichthyophthirius
11/07/2001	EP1151098A1 Malaria vaccine
11/07/2001	EP1151097A1 Haemophilus influenzae rd outer membrane sequences used as vaccine
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151011A1 Anti-ccr1 antibodies and methods of use therefor
11/07/2001	EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001	EP1151005A1 Peptide variants of the tumour marker muc1 and the use thereof
11/07/2001	EP1151003A1 Novel fibronectin-binding protein
11/07/2001	EP1151002A1 Antibodies specific to kdr and uses thereof
11/07/2001	EP1150918A2 Therapeutic calcium phosphate particles and methods of manufacture and use
11/07/2001	EP1150714A2 Methods for inhibiting brain tumor growth
11/07/2001	EP1150713A2 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
11/07/2001	EP1150712A2 Human papilloma virus vaccine formulations
11/07/2001	EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
11/07/2001	EP1150710A1 Immunogenic complexes and methods relating thereto
11/07/2001	EP1150709A2 Anti-microbial agents, diagnostic reagents, and vaccines based on apicomplexan parasite components
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	EP1150693A1 Immunogenic compositions for use as vaccines
11/07/2001	EP1150688A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP0975380B1 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
11/07/2001	EP0845007B1 Pharmaceutical composition containing inhibitors of interferon-gamma
11/07/2001	EP0824699B1 Compounds and methods for diagnosis of leishmaniasis
11/07/2001	EP0689596B1 Stimulation of immune response by viral protein
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321189A Method for inducing cellular immunity and cells with induced cellular immunity
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
11/07/2001	CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide
11/07/2001	CN1320636A Polypeptide-human protein 9 containing porin characteristic sequence fragment and polynucleotide for coding it
11/07/2001	CN1320605A Anticancer precursor compound containing anthracycle cytotoxins, its preparing process and its medicine
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/07/2001	CN1074296C Method for preparing oral medicine using silkworm to express hepatitis C antigen
11/06/2001	USRE37437 Sheet-like diagnostic device
11/06/2001	US6313369 Wound healing agents
11/06/2001	US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae
11/06/2001	US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it
11/06/2001	US6313270 DbpB
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313263 γ, δ T cell receptor and methods for detection
11/06/2001	US6312944 Nucleotide sequences coding microorganism poylpeptide; fo r use as diagnostic tool in genetic engineering
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases
11/06/2001	US6312915 Tick (Ixodes scapularis) vector saliva-induced Lyme disease spirochete (Borrelia burgdorferi) antigens as vaccine candidates
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312737 The cancer cells can be leukemia cells and prostate cancer cells.
11/06/2001	US6312732 Biodegradable targetable microparticle delivery system
11/06/2001	US6312731 Polymer and swelling
11/06/2001	US6312718 Liposomal composition, b-cell malignancy antigen and lipids
11/06/2001	US6312711 Vehicles for food and drugs, stress proteins, sequential epitopes of antigen structure
11/06/2001	US6312703 Drugs or cosmetics, liquid crystal solids and lecithin
11/06/2001	US6312700 Fusion proteins and receptors
11/06/2001	US6312696 Isolated dna molecules with polypeptide codes and amino acid sequences
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/06/2001	US6312691 Treating tumors
11/06/2001	US6312689 Antibodies or antigens
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/06/2001	CA1341315C Targeted forms of methyltrithio antitumor agents
11/01/2001	WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a
11/01/2001	WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081584A2 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
11/01/2001	WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081579A1 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081423A1 Antibodies against native gp96, production and use thereof
11/01/2001	WO2001081422A1 Secretory tyrosine phosphatases from mycobacteria
11/01/2001	WO2001081417A2 Use of taci as an anti-tumor agent
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081388A1 Composition containing leishmania lip2a
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001081379A2 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2001081371A1 Gd3-mimetic peptides
11/01/2001	WO2001081361A1 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death
11/01/2001	WO2001080897A2 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	WO2001080889A1 Product and process for regulation of t cell responses
11/01/2001	WO2001080888A2 Method for treatment of tumors using photodynamic therapy
11/01/2001	WO2001080887A2 Methods and chemokin compositions for inducing an immune response
11/01/2001	WO2001080886A2 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
11/01/2001	WO2001080885A2 Equine protozoal myeloencephalitis vaccine
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080882A2 Methods and compositions for eliciting an immune response
11/01/2001	WO2001080881A1 Vaccine comprising a tick cement protein
11/01/2001	WO2001080880A2 Apoptotic agents
11/01/2001	WO2001080879A2 Colorectal cancer vaccines and diagnosis
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080836A1 Use of particulate vectors in immunomodulation

1 ... 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 ... 1823